Cite
Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence
MLA
Graham Wood, et al. “Clinical Utility of ANA Measured by ELISA Compared with ANA Measured by Immunofluorescence.” Rheumatology, vol. 48, June 2009, pp. 1013–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dca12016eb5d47dcf35c3ac583570750&authtype=sso&custid=ns315887.
APA
Graham Wood, Sally Houghton, Gerald A. Maguire, Anita Y. N. Lim, Hill Gaston, Dinakantha S. Kumararatne, Amel Ginawi, & Jeffrey Lee. (2009). Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence. Rheumatology, 48, 1013–1014.
Chicago
Graham Wood, Sally Houghton, Gerald A. Maguire, Anita Y. N. Lim, Hill Gaston, Dinakantha S. Kumararatne, Amel Ginawi, and Jeffrey Lee. 2009. “Clinical Utility of ANA Measured by ELISA Compared with ANA Measured by Immunofluorescence.” Rheumatology 48 (June): 1013–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dca12016eb5d47dcf35c3ac583570750&authtype=sso&custid=ns315887.